Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.

MLA

Cani, Alice, et al. “Triple Akt Inhibition as a New Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia.” Oncotarget, vol. 6, no. 9, Mar. 2015, pp. 6597–610. EBSCOhost, https://doi.org/10.18632/oncotarget.3260.

APA

Cani, A., Simioni, C., Martelli, A. M., Zauli, G., Tabellini, G., Ultimo, S., McCubrey, J. A., Capitani, S., & Neri, L. M. (2015). Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia. Oncotarget, 6(9), 6597–6610. https://doi.org/10.18632/oncotarget.3260

Chicago

Cani, Alice, Carolina Simioni, Alberto M Martelli, Giorgio Zauli, Giovanna Tabellini, Simona Ultimo, James A McCubrey, Silvano Capitani, and Luca M Neri. 2015. “Triple Akt Inhibition as a New Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia.” Oncotarget 6 (9): 6597–6610. doi:10.18632/oncotarget.3260.